Ambion has recently introduced the ArrayScript reverse transcriptase, a modified enzyme that the company said produces “up to twice as much cRNA as wild-type M-MLV or AMV and other engineered M-MLV reverse transcriptases when low amounts of total RNA are used.”
Details on the product can be found at . http://www.ambion.com/catalog/CatNum.php?2048.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.